Yes it overvalued when compared to a biotech like Novogen which has much better downside protection and massive upside.
Still, once they start selling their product the risk profile will change. People are just getting in early.
I would buy them on a pull back to $4.50.
Looks like my $6 close target will get pretty close.
- Forums
- ASX - By Stock
- CMQ
- ????????
????????, page-3
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online